| Election night agenda: When polls close and when to expect results |
AP Online |
11/03 |
07:02 |
| Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Globe Newswire |
11/03 |
07:01 |
| Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| OutSolve Named a 2026 Inc. Power Partner for Business Products and Services |
Globe Newswire |
11/03 |
07:00 |
| ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
| LGI Homes, Inc. Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Fiserv Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| OTC Markets Group Announces Quarterly Index Performance and Rebalancing |
Globe Newswire |
11/03 |
07:00 |
| Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion |
Globe Newswire |
11/03 |
07:00 |
| Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22% |
Globe Newswire |
11/03 |
07:00 |
| InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day |
Globe Newswire |
11/03 |
07:00 |
| Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients |
Globe Newswire |
11/03 |
07:00 |
| Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors |
Globe Newswire |
11/03 |
07:00 |
| Strata Critical Medical Announces Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Seyond Expands Smart City Solution with LiDAR-Powered Operational Twin Capabilities and Technology Collaborations |
Globe Newswire |
11/03 |
07:00 |
| Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
| Maze Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/03 |
07:00 |
| Cartesian Therapeutics Announces New Employment Inducement Grant |
Globe Newswire |
11/03 |
07:00 |
| First Watch Restaurant Group, Inc. Reports Q3 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Talen Energy Reports Third Quarter 2026 Results, Reaffirms 2026 Guidance, and Introduces 2027 Guidance |
Globe Newswire |
11/03 |
07:00 |
| Luckin Coffee Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Beam Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Clinical Progress Across Base Editing Portfolio |
Globe Newswire |
11/03 |
07:00 |
| Sportradar Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/03 |
07:00 |
| Rapport Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/03 |
07:00 |
| Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update |
Globe Newswire |
11/03 |
07:00 |
